Interleukins in cancer: from biology to therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 34083781.
- Also identified by DOI 10.1038/s41568-021-00363-z and PMC identifier 8173513.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interleukins and associated cytokines serve as the means of communication for innate and adaptive immune cells as well as non-immune cells and tissues. Thus, interleukins have a critical role in cancer development, progression and control. Interleukins can nurture an environment enabling and favouring cancer growth while simultaneously being essential for a productive tumour-directed immune response. These properties of interleukins can be exploited to improve immunotherapies to promote effectiveness as well as to limit side effects. This Review aims to unravel some of these complex interactions.
Medical subject headings
- Immunotherapy
- Interleukins
- Neoplasms